US5271961A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for producing protein microspheres
Assignee: Alkermes Controlled Therapeutics Inc
•
Filing: 1992-06-23
•
Granted: 1993-12-21
•
Expires: 2012-06-23
Abstract
Abstract Protein microspheres are formed by phase separation in a non-solvent followed by solvent removal. The preferred proteins are prolamines, such as zein, that are hydrophobic, biodegradable, and can be modified proteolytically or chemically to endow them with desirable properties, such as a selected degradation rate. Composite microspheres can be prepared from a mixture of proteins or a mixture of proteins with one or more bioerodible polymeric materials, such as polylactides. Protein coatings can also be made. Compounds are readily incorporated into the microspheres for subsequent release. The process does not involve agents which degrade most labile proteins. The microspheres have a range of sizes and multiple applications, including drug delivery and delayed release of pesticides, fertilizers, and agents for environmental cleanup. Selection of microsphere size in the range of less than five microns and mode of administration can be used to target the microparticles to the cells of the reticuloendothelial system, or to the mucosal membranes of the mouth or gastrointestinal tract. Larger implants formed from the microspheres can also be utilized, especially for agricultural applications.
Inventors
- 👤 Edith Mathiowitz
- 👤 Howard Bernstein
- 👤 Eric Morrel
- 👤 Kirsten Schwaller
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 01:48
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1658; A61K9/1641; A61K9/1647; A61K9/48; A61K9/50; A61K9/5005; A61K9/5021; A61K9/5052
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
133 words
A method for producing protein microspheres comprising the steps of: a) contacting a prolamine solution, wherein the prolamine solution contains at least one type of prolamine and a compound to be incorporated into the microspheres, with a second liquid, wherein the second liquid is of limited miscibility with the prolamine solvent such that the second liquid does not form a stable homogeneous solution with the prolamine solvent and does not dissolve the prolamine, in a ratio of prolamine solution to second liquid of at least 1:20, to form a prolamine-non-solvent mixture; b) agitating the prolamine-non-solvent mixture to form a dispersion of the prolamine solution in the second liquid at a temperature of less than about 65° C.; and c) removing the prolamine solvent to form stable prolamine microspheres without crosslinking or heat denaturation.
Claim 2
Independent Claim
133 words
A method for producing protein microspheres comprising the steps of: a) contacting a prolamine solution, wherein the prolamine solution contains at least one type of prolamine and a compound to be incorporated into the microspheres, with a second liquid, wherein the second liquid is of limited miscibility with the prolamine solvent such that the second liquid does not form a stable homogeneous solution with the prolamine solvent and does not dissolve the prolamine, in a ratio of prolamine solution to second liquid of at least 1:20, to form a prolamine-non-solvent mixture; b) agitating the prolamine-non-solvent mixture to form a dispersion of the prolamine solution in the second liquid at a temperature of less than about 65° C.; and c) removing the prolamine solvent to form stable prolamine microspheres without crosslinking or heat denaturation.
Claim 3
Dependent Claim
20 words
The method of claim 1 wherein the prolamine is selected from the group consisting of zein, gliadin, hordein and kafirin.
Claim 4
Dependent Claim
38 words
The method of claim 1 comprising, prior to forming the prolamine solution, modifying the prolamine to enhance or alter one of the properties of thermal stability, surface reactivity, lipophilicity, molecular weight, charge, shear stability or resistance to proteases.
Claim 5
Dependent Claim
11 words
The method of claim 3 wherein the prolamine is chemically modified.
Claim 6
Dependent Claim
12 words
The method of claim 4 wherein the prolamine is deamidated with acid.
Claim 7
Dependent Claim
17 words
The method of claim 4 wherein the prolamine is chemically modified by esterification with a fatty alcohol.
Claim 8
Dependent Claim
17 words
The method of claim 4 wherein the prolamine is chemically modified by acylation with a fatty anhydride.
Claim 9
Dependent Claim
21 words
The method of claim 4 wherein the prolamine is chemically modified by coupling amino acids, peptides, or proteins to the prolamine.
Claim 10
Dependent Claim
16 words
The method of claim 3 wherein the prolamine is cleaved enzymatically into smaller molecular weight fragments.
Claim 11
Dependent Claim
74 words
The method of claim 1 wherein the prolamine solvent is selected from the group consisting of alcohols, ketones, and amide solvents, aqueous mixtures of alcohols, ketones, and amide solvents containing no more than 60% water, solutions having pH of 10 or more, solutions having pH of 2 or less, aqueous solutions of inorganic salts in concentrations of from about 1.0 to about 6N, and binary alcohols and halogenated hydrocarbons or polyols, and combinations thereof.
Claim 12
Dependent Claim
28 words
The method of claim 1 wherein the second liquid is selected from the group consisting of oils, hexane, heptane, dodecane, high boiling point petroleum ether, and combinations thereof.
Claim 13
Dependent Claim
18 words
The method of claim 1 further comprising a compound selected from the group consisting of surfactants and binders.
Claim 14
Dependent Claim
22 words
The method of claim 1 further comprising mixing a non-protein polymer with the prolamine containing incorporated drug to form composite prolamine microspheres.
Claim 15
Dependent Claim
29 words
The method of claim 13 wherein the polymer is selected from the group consisting of poly(lactic acid)s, poly(glycolic acid)s, polyanhydrides, polyorthoesters, polycaprolactones, polyphosphazenes, polyhydroxybutyrates, polyamides, blends and copolymers thereof.
Claim 16
Dependent Claim
19 words
The method of claim 1 further comprising adding particles insoluble in the prolamine solution to form prolamine coated particles.
Claim 17
Dependent Claim
18 words
The method of claim 15 wherein the particles are selected from the group consisting of microspheres and microcapsules.
Claim 18
Dependent Claim
27 words
The method of claim 15 wherein the particles are formed of a material selected from the group consisting of proteins, inorganic salts, polysaccharides, metals and non-protein polymers.
Claim 19
Dependent Claim
27 words
The method of claim 1 wherein the compound is selected from the group of biologically active compounds consisting of pharmaceuticals, pesticides, nutrients, imaging agents, and chelating agents.
Claim 20
Dependent Claim
14 words
The method of claim 1 wherein the compound is soluble in the prolamine solution.
Claim 21
Dependent Claim
14 words
The method of claim 1 wherein the compound is insoluble in the prolamine solution.
References Cited (Backward Citations)
US3092553A
Cited
US3116206A
Cited
US3937668A
Cited
US3943063A
Cited
US4107288A
Cited
US4194013A
Cited
EP0000667A1
Cited
US4420442A
Cited
US4818542A
Cited
US4876094A
Cited
GB2166651A
Cited
US4940588A
Cited
US4952402A
Cited
GB2224258A
Cited
WO1990003123A2
Cited
US5021248A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-12-20 | 1997-06-21 | 1997-12-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-12-20 | 2001-06-21 | 2001-12-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-12-20 | 2005-06-21 | 2005-12-21 | $7700.00 | Window Closed / Lapsed |